SLGL
Sol-gelยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SLGL Profile
Sol-Gel Technologies Ltd.
A dermatology company focused on generic topical drug products for the treatment of skin diseases
7 Golda Meir St., Weizmann Science Park , Ness Ziona, 7403650, Israel
--
Sol-gel Technologies Ltd. Incorporated under the laws of the State of Israel on October 28, 1997. The company is an innovative dermatology company with a successful track record of two NDA approvals and a pipeline of advanced product candidates under development for orphan indications. Sol-Gel successfully developed pioneering topical drugs Twyneo and Epsolay, which were approved for the treatment of rosacea and inflammatory lesions, respectively.
